Pamela Paris, PhD

Title(s)Professor Emeritus, Urology
SchoolSchool of Medicine
Address1450 Third Street, #001
San Francisco CA 94158
Phone415-514-2559
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Research Interests

    Our laboratory conducts translational cancer genomics research. The overarching goal is to identify drug targets with associated prognostic biomarkers. To date, their primary focus has been primary and metastatic prostate cancer.

    Collapse Research 
    Collapse Research Activities and Funding
    External validation of GEMCaP, a prognostic DNA biomarker set for CaP recurrence
    NIH R01CA158200Apr 5, 2011 - Sep 30, 2016
    Role: Principal Investigator
    CaP Metastasis Biomarkers: Validation/Genomics/Biology
    NIH R01CA115484Sep 1, 2005 - Jun 30, 2011
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Evaluation of Culture Conducive to Academic Success by Gender at a Comprehensive Cancer Center. Oncologist. 2024 Mar 04; 29(3):e351-e359. Keenan BP, Sibley A, Zhang L, Westring AF, Velazquez AI, Bank EM, Bergsland EK, Boreta L, Conroy P, Daras M, Hermiston M, Hsu G, Paris PL, Piawah S, Sinha S, Sosa JA, Tsang M, Venook AP, Wong M, Yom SS, Van Loon K. PMID: 37440206; PMCID: PMC10911925.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    2. A Phase Ib/II Study of the CDK4/6 Inhibitor Ribociclib in Combination with Docetaxel plus Prednisone in Metastatic Castration-Resistant Prostate Cancer. Clin Cancer Res. 2022 04 14; 28(8):1531-1539. de Kouchkovsky I, Rao A, Carneiro BA, Zhang L, Lewis C, Phone A, Small EJ, Friedlander T, Fong L, Paris PL, Ryan CJ, Szmulewitz RZ, Aggarwal R. PMID: 35176163.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    3. Cell-Free DNA Detection of Tumor Mutations in Heterogeneous, Localized Prostate Cancer Via Targeted, Multiregion Sequencing. JCO Precis Oncol. 2021; 5. Chen E, Cario CL, Leong L, Lopez K, Márquez CP, Li PS, Oropeza E, Tenggara I, Cowan J, Simko JP, Kageyama R, Wells DK, Chan JM, Friedlander T, Aggarwal R, Paris PL, Feng F, Carroll PR, Witte JS. PMID: 34250416; PMCID: PMC8232833.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    4. Plasma miRNA Biomarkers in Limited Volume Samples for Detection of Early-stage Pancreatic Cancer. Cancer Prev Res (Phila). 2021 07; 14(7):729-740. Dittmar RL, Liu S, Tai MC, Rajapakshe K, Huang Y, Longton G, DeCapite C, Hurd MW, Paris PL, Kirkwood KS, Coarfa C, Maitra A, Brand RE, Killary AM, Sen S. PMID: 33893071; PMCID: PMC8818322.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    5. Cell-free DNA concentration and fragment size as a biomarker for prostate cancer. Sci Rep. 2021 03 03; 11(1):5040. Chen E, Cario CL, Leong L, Lopez K, Márquez CP, Chu C, Li PS, Oropeza E, Tenggara I, Cowan J, Simko JP, Chan JM, Friedlander T, Wyatt AW, Aggarwal R, Paris PL, Carroll PR, Feng F, Witte JS. PMID: 33658587; PMCID: PMC7930042.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    6. Multiple Tissue Biomarkers Independently and Additively Predict Prostate Cancer Pathology Outcomes. Eur Urol. 2021 01; 79(1):141-149. Cooperberg MR, Cowan JE, Lindquist KJ, Kobayashi Y, Simko JP, Bengtsson H, Singh K, Ngo V, Avila A, Newcomb LF, Tretriakova M, Lin DW, Stone S, Carroll PR, Paris PL. PMID: 33148472.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    7. A machine learning approach to optimizing cell-free DNA sequencing panels: with an application to prostate cancer. BMC Cancer. 2020 Aug 28; 20(1):820. Cario CL, Chen E, Leong L, Emami NC, Lopez K, Tenggara I, Simko JP, Friedlander TW, Li PS, Paris PL, Carroll PR, Witte JS. PMID: 32859160; PMCID: PMC7456018.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    8. Breast and prostate cancers harbor common somatic copy number alterations that consistently differ by race and are associated with survival. BMC Med Genomics. 2020 08 20; 13(1):116. Chen Y, Sadasivan SM, She R, Datta I, Taneja K, Chitale D, Gupta N, Davis MB, Newman LA, Rogers CG, Paris PL, Li J, Rybicki BA, Levin AM. PMID: 32819446; PMCID: PMC7441621.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    9. Identification and Characterization of Circulating Tumor Cells in Men Who have Undergone Prostatectomy for Clinically Localized, High Risk Prostate Cancer. J Urol. 2019 10; 202(4):732-741. Friedlander TW, Welty C, Anantharaman A, Schonhoft JD, Jendrisak A, Lee J, Li P, Hough J, Stromlund A, Edwards M, Sangar S, Kobayashi Y, Simko J, Farrokhian N, Lindquist K, Greene S, Ontiveros P, Graf R, Rodriquez A, Suraneni M, Wang Y, Landers M, Carroll P, Cooperberg MR, Dittamore R, Paris PL. PMID: 31216253.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    10. Targeting CD46 for both adenocarcinoma and neuroendocrine prostate cancer. JCI Insight. 2018 09 06; 3(17). Su Y, Liu Y, Behrens CR, Bidlingmaier S, Lee NK, Aggarwal R, Sherbenou DW, Burlingame AL, Hann BC, Simko JP, Premasekharan G, Paris PL, Shuman MA, Seo Y, Small EJ, Liu B. PMID: 30185663; PMCID: PMC6171802.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansAnimalsCells
    11. Copy number gains at chr3p25 and chr11p11 are associated with lymph node involvement and survival in muscle-invasive bladder tumors. PLoS One. 2017; 12(11):e0187975. Lindquist KJ, Sanford T, Friedlander TW, Paris PL, Porten SP. PMID: 29140994; PMCID: PMC5687759.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    12. Validation of GEMCaP as a DNA Based Biomarker to Predict Prostate Cancer Recurrence after Radical Prostatectomy. J Urol. 2018 03; 199(3):719-725. Nguyen HG, Welty C, Lindquist K, Ngo V, Gilbert E, Bengtsson H, Magi-Galluzzi C, Jean-Gilles J, Yao J, Cooperberg M, Messing E, Klein EA, Carroll PR, Paris PL. PMID: 28941923.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    13. Measurement of copy number variation in single cancer cells using rapid-emulsification digital droplet MDA. Microsyst Nanoeng. 2017; 3. Kim SC, Premasekharan G, Clark IC, Gemeda HB, Paris PL, Abate AR. PMID: 30147985; PMCID: PMC6108428.
      View in: PubMed   Mentions: 4  
    14. Real-Time Transferrin-Based PET Detects MYC-Positive Prostate Cancer. Mol Cancer Res. 2017 09; 15(9):1221-1229. Aggarwal R, Behr SC, Paris PL, Truillet C, Parker MFL, Huynh LT, Wei J, Hann B, Youngren J, Huang J, Premasekharan G, Ranatunga N, Chang E, Gao KT, Ryan CJ, Small EJ, Evans MJ. PMID: 28592703; PMCID: PMC5581675.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    15. High-Dose Abiraterone Acetate in Men With Castration Resistant Prostate Cancer. Clin Genitourin Cancer. 2017 12; 15(6):733-741.e1. Friedlander TW, Graff JN, Zejnullahu K, Anantharaman A, Zhang L, Paz R, Premasekharan G, Russell C, Huang Y, Kim W, Aggarwal RR, Lin AM, Fong L, Alumkal JJ, Beer TM, Sharifi N, Alyamani M, Dittamore R, Small EJ, Paris PL, Ryan CJ. PMID: 28655452.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    16. Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients. BMC Cancer. 2016 Sep 22; 16(1):744. Anantharaman A, Friedlander T, Lu D, Krupa R, Premasekharan G, Hough J, Edwards M, Paz R, Lindquist K, Graf R, Jendrisak A, Louw J, Dugan L, Baird S, Wang Y, Dittamore R, Paris PL. PMID: 27658492; PMCID: PMC5034508.
      View in: PubMed   Mentions: 64     Fields:    
    17. An improved CTC isolation scheme for pairing with downstream genomics: Demonstrating clinical utility in metastatic prostate, lung and pancreatic cancer. Cancer Lett. 2016 09 28; 380(1):144-52. Premasekharan G, Gilbert E, Okimoto RA, Hamirani A, Lindquist KJ, Ngo VT, Roy R, Hough J, Edwards M, Paz R, Foye A, Sood R, Copren KA, Gubens M, Small EJ, Bivona TG, Collisson EA, Friedlander TW, Paris PL. PMID: 27343980.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    18. Mutational Landscape of Aggressive Prostate Tumors in African American Men. Cancer Res. 2016 04 01; 76(7):1860-8. Lindquist KJ, Paris PL, Hoffmann TJ, Cardin NJ, Kazma R, Mefford JA, Simko JP, Ngo V, Chen Y, Levin AM, Chitale D, Helfand BT, Catalona WJ, Rybicki BA, Witte JS. PMID: 26921337; PMCID: PMC4772140.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    19. Associations between circulating carotenoids, genomic instability and the risk of high-grade prostate cancer. Prostate. 2016 Mar; 76(4):339-48. Nordström T, Van Blarigan EL, Ngo V, Roy R, Weinberg V, Song X, Simko J, Carroll PR, Chan JM, Paris PL. PMID: 26585352; PMCID: PMC5493324.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    20. Circulating Tumor Cells as Potential Biomarkers in Bladder Cancer. J Urol. 2015 Sep; 194(3):790-8. Alva A, Friedlander T, Clark M, Huebner T, Daignault S, Hussain M, Lee C, Hafez K, Hollenbeck B, Weizer A, Premasekharan G, Tran T, Fu C, Ionescu-Zanetti C, Schwartz M, Fan A, Paris P. PMID: 25912492; PMCID: PMC5103704.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCells
    21. Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer. Clin Cancer Res. 2015 May 15; 21(10):2315-24. Azad AA, Volik SV, Wyatt AW, Haegert A, Le Bihan S, Bell RH, Anderson SA, McConeghy B, Shukin R, Bazov J, Youngren J, Paris P, Thomas G, Small EJ, Wang Y, Gleave ME, Collins CC, Chi KN. PMID: 25712683.
      View in: PubMed   Mentions: 209     Fields:    Translation:HumansCells
    22. Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma. Nat Med. 2014 Dec; 20(12):1394-6. Hashizume R, Andor N, Ihara Y, Lerner R, Gan H, Chen X, Fang D, Huang X, Tom MW, Ngo V, Solomon D, Mueller S, Paris PL, Zhang Z, Petritsch C, Gupta N, Waldman TA, James CD. PMID: 25401693; PMCID: PMC4257862.
      View in: PubMed   Mentions: 246     Fields:    Translation:HumansAnimalsCells
    23. Next generation sequencing of pancreatic cyst fluid microRNAs from low grade-benign and high grade-invasive lesions. Cancer Lett. 2015 Jan 28; 356(2 Pt B):404-9. Wang J, Paris PL, Chen J, Ngo V, Yao H, Frazier ML, Killary AM, Liu CG, Liang H, Mathy C, Bondada S, Kirkwood K, Sen S. PMID: 25304377; PMCID: PMC6200344.
      View in: PubMed   Mentions: 66     Fields:    Translation:Humans
    24. Single-cell genetic analysis reveals insights into clonal development of prostate cancers and indicates loss of PTEN as a marker of poor prognosis. Am J Pathol. 2014 Oct; 184(10):2671-86. Heselmeyer-Haddad KM, Berroa Garcia LY, Bradley A, Hernandez L, Hu Y, Habermann JK, Dumke C, Thorns C, Perner S, Pestova E, Burke C, Chowdhury SA, Schwartz R, Schäffer AA, Paris PL, Ried T. PMID: 25131421; PMCID: PMC4188868.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    25. Performance of the Genomic Evaluators of Metastatic Prostate Cancer (GEMCaP) tumor biomarker for identifying recurrent disease in African American patients. Cancer Epidemiol Biomarkers Prev. 2014 Aug; 23(8):1677-82. Levin AM, Lindquist KJ, Avila A, Witte JS, Paris PL, Rybicki BA. PMID: 24891551; PMCID: PMC4119547.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    26. Recurrent epimutations activate gene body promoters in primary glioblastoma. Genome Res. 2014 May; 24(5):761-74. Nagarajan RP, Zhang B, Bell RJ, Johnson BE, Olshen AB, Sundaram V, Li D, Graham AE, Diaz A, Fouse SD, Smirnov I, Song J, Paris PL, Wang T, Costello JF. PMID: 24709822; PMCID: PMC4009606.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    27. Detection and characterization of invasive circulating tumor cells derived from men with metastatic castration-resistant prostate cancer. Int J Cancer. 2014 May 15; 134(10):2284-93. Friedlander TW, Ngo VT, Dong H, Premasekharan G, Weinberg V, Doty S, Zhao Q, Gilbert EG, Ryan CJ, Chen WT, Paris PL. PMID: 24166007.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansCells
    28. Looking back, to the future of circulating tumor cells. Pharmacol Ther. 2014 Jun; 142(3):271-80. Friedlander TW, Premasekharan G, Paris PL. PMID: 24362084.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansAnimalsCells
    29. Common structural and epigenetic changes in the genome of castration-resistant prostate cancer. Cancer Res. 2012 Feb 01; 72(3):616-25. Friedlander TW, Roy R, Tomlins SA, Ngo VT, Kobayashi Y, Azameera A, Rubin MA, Pienta KJ, Chinnaiyan A, Ittmann MM, Ryan CJ, Paris PL. PMID: 22158653.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansCells
    30. Detection of recurrent rearrangement breakpoints from copy number data. BMC Bioinformatics. 2011 Apr 21; 12:114. Ritz A, Paris PL, Ittmann MM, Collins C, Raphael BJ. PMID: 21510904; PMCID: PMC3112242.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    31. A group of genome-based biomarkers that add to a Kattan nomogram for predicting progression in men with high-risk prostate cancer. Clin Cancer Res. 2010 Jan 01; 16(1):195-202. Paris PL, Weinberg V, Albo G, Roy R, Burke C, Simko J, Carroll P, Collins C. PMID: 20028763; PMCID: PMC2854027.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    32. Functional phenotyping and genotyping of circulating tumor cells from patients with castration resistant prostate cancer. Cancer Lett. 2009 May 18; 277(2):164-73. Paris PL, Kobayashi Y, Zhao Q, Zeng W, Sridharan S, Fan T, Adler HL, Yera ER, Zarrabi MH, Zucker S, Simko J, Chen WT, Rosenberg J. PMID: 19162393.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCells
    33. A whole-genome amplification protocol for a wide variety of DNAs, including those from formalin-fixed and paraffin-embedded tissue. Methods Mol Biol. 2009; 556:89-98. Paris PL. PMID: 19488873.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    34. An oncogenic role for the multiple endocrine neoplasia type 1 gene in prostate cancer. Prostate Cancer Prostatic Dis. 2009; 12(2):184-91. Paris PL, Sridharan S, Hittelman AB, Kobayashi Y, Perner S, Huang G, Simko J, Carroll P, Rubin MA, Collins C. PMID: 18779856; PMCID: PMC2844124.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    35. Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications. Clin Cancer Res. 2008 Jun 01; 14(11):3380-5. Mosquera JM, Perner S, Genega EM, Sanda M, Hofer MD, Mertz KD, Paris PL, Simko J, Bismar TA, Ayala G, Shah RB, Loda M, Rubin MA. PMID: 18519767; PMCID: PMC3717517.
      View in: PubMed   Mentions: 88     Fields:    Translation:Humans
    36. A sequence-based survey of the complex structural organization of tumor genomes. Genome Biol. 2008; 9(3):R59. Raphael BJ, Volik S, Yu P, Wu C, Huang G, Linardopoulou EV, Trask BJ, Waldman F, Costello J, Pienta KJ, Mills GB, Bajsarowicz K, Kobayashi Y, Sridharan S, Paris PL, Tao Q, Aerni SJ, Brown RP, Bashir A, Gray JW, Cheng JF, de Jong P, Nefedov M, Ried T, Padilla-Nash HM, Collins CC. PMID: 18364049; PMCID: PMC2397511.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    37. Evaluation of whole genome amplification protocols for array and oligonucleotide CGH. Diagn Mol Pathol. 2007 Dec; 16(4):198-206. Hittelman A, Sridharan S, Roy R, Fridlyand J, Loda M, Collins C, Paris PL. PMID: 18043282.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    38. High resolution oligonucleotide CGH using DNA from archived prostate tissue. Prostate. 2007 Sep 15; 67(13):1447-55. Paris PL, Sridharan S, Scheffer A, Tsalenko A, Bruhn L, Collins C. PMID: 17654530; PMCID: PMC2844769.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    39. TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion. Am J Surg Pathol. 2007 Jun; 31(6):882-8. Perner S, Mosquera JM, Demichelis F, Hofer MD, Paris PL, Simko J, Collins C, Bismar TA, Chinnaiyan AM, De Marzo AM, Rubin MA. PMID: 17527075.
      View in: PubMed   Mentions: 193     Fields:    Translation:Humans
    40. Morphological features of TMPRSS2-ERG gene fusion prostate cancer. J Pathol. 2007 May; 212(1):91-101. Mosquera JM, Perner S, Demichelis F, Kim R, Hofer MD, Mertz KD, Paris PL, Simko J, Collins C, Bismar TA, Chinnaiyan AM, Rubin MA. PMID: 17385188.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    41. Genomic profiling of hormone-naïve lymph node metastases in patients with prostate cancer. Neoplasia. 2006 Dec; 8(12):1083-9. Paris PL, Hofer MD, Albo G, Kuefer R, Gschwend JE, Hautmann RE, Fridyland J, Simko J, Carroll PR, Rubin MA, Collins C. PMID: 17217626; PMCID: PMC1783716.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    42. Decoding the fine-scale structure of a breast cancer genome and transcriptome. Genome Res. 2006 Mar; 16(3):394-404. Volik S, Raphael BJ, Huang G, Stratton MR, Bignel G, Murnane J, Brebner JH, Bajsarowicz K, Paris PL, Tao Q, Kowbel D, Lapuk A, Shagin DA, Shagina IA, Gray JW, Cheng JF, de Jong PJ, Pevzner P, Collins C. PMID: 16461635; PMCID: PMC1415204.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    43. Preliminary evaluation of prostate cancer metastatic risk biomarkers. Int J Biol Markers. 2005 Jul-Sep; 20(3):141-5. Paris PL, Weinberg V, Simko J, Andaya A, Albo G, Rubin MA, Carroll PR, Collins C. PMID: 16247872.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    44. Construction and application of a full-coverage, high-resolution, human chromosome 8q genomic microarray for comparative genomic hybridization. Cytometry A. 2005; 63(1):10-9. van Duin M, van Marion R, Watson JE, Paris PL, Lapuk A, Brown N, Oseroff VV, Albertson DG, Pinkel D, de Jong P, Nacheva EP, Dinjens W, van Dekken H, Collins C. PMID: 15619731.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    45. Evolution of 8p loss in transformed human prostate epithelial cells. Cancer Genet Cytogenet. 2004 Oct 01; 154(1):36-43. Macoska JA, Paris P, Collins C, Andaya A, Beheshti B, Chaib H, Kant R, Begley L, MacDonald JW, Squire JA. PMID: 15381370.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    46. Molecular analysis of WFDC1/ps20 gene in prostate cancer. Prostate. 2004 Oct 01; 61(2):192-9. Watson JE, Kamkar S, James K, Kowbel D, Andaya A, Paris PL, Simko J, Carroll P, McAlhany S, Rowley D, Collins C. PMID: 15305342.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    47. An analysis of CTLA-4 and proinflammatory cytokine genes in Wegener's granulomatosis. Arthritis Rheum. 2004 Aug; 50(8):2645-50. Zhou Y, Huang D, Paris PL, Sauter CS, Prock KA, Hoffman GS. PMID: 15334480.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    48. Overexpression, amplification, and androgen regulation of TPD52 in prostate cancer. Cancer Res. 2004 Jun 01; 64(11):3814-22. Rubin MA, Varambally S, Beroukhim R, Tomlins SA, Rhodes DR, Paris PL, Hofer MD, Storz-Schweizer M, Kuefer R, Fletcher JA, Hsi BL, Byrne JA, Pienta KJ, Collins C, Sellers WR, Chinnaiyan AM. PMID: 15172988.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansCells
    49. Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors. Hum Mol Genet. 2004 Jul 01; 13(13):1303-13. Paris PL, Andaya A, Fridlyand J, Jain AN, Weinberg V, Kowbel D, Brebner JH, Simko J, Watson JE, Volik S, Albertson DG, Pinkel D, Alers JC, van der Kwast TH, Vissers KJ, Schroder FH, Wildhagen MF, Febbo PG, Chinnaiyan AM, Pienta KJ, Carroll PR, Rubin MA, Collins C, van Dekken H. PMID: 15138198.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansCells
    50. Integration of high-resolution array comparative genomic hybridization analysis of chromosome 16q with expression array data refines common regions of loss at 16q23-qter and identifies underlying candidate tumor suppressor genes in prostate cancer. Oncogene. 2004 Apr 22; 23(19):3487-94. Watson JE, Doggett NA, Albertson DG, Andaya A, Chinnaiyan A, van Dekken H, Ginzinger D, Haqq C, James K, Kamkar S, Kowbel D, Pinkel D, Schmitt L, Simko JP, Volik S, Weinberg VK, Paris PL, Collins C. PMID: 15007382.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    51. Association of prostate cancer risk and aggressiveness to androgen pathway genes: SRD5A2, CYP17, and the AR. Prostate. 2004 Apr 01; 59(1):69-76. Cicek MS, Conti DV, Curran A, Neville PJ, Paris PL, Casey G, Witte JS. PMID: 14991867.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    52. Comprehensive evaluation of the association between prostate cancer and genotypes/haplotypes in CYP17A1, CYP3A4, and SRD5A2. Eur J Hum Genet. 2004 Apr; 12(4):321-32. Loukola A, Chadha M, Penn SG, Rank D, Conti DV, Thompson D, Cicek M, Love B, Bivolarevic V, Yang Q, Jiang Y, Hanzel DK, Dains K, Paris PL, Casey G, Witte JS. PMID: 14560315.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    53. Evaluation of genetic patterns in different tumor areas of intermediate-grade prostatic adenocarcinomas by high-resolution genomic array analysis. Genes Chromosomes Cancer. 2004 Mar; 39(3):249-56. van Dekken H, Paris PL, Albertson DG, Alers JC, Andaya A, Kowbel D, van der Kwast TH, Pinkel D, Schröder FH, Vissers KJ, Wildhagen MF, Collins C. PMID: 14732926.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    54. CYP3A4 and CYP3A5 genotypes, haplotypes, and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2003 Sep; 12(9):928-32. Plummer SJ, Conti DV, Paris PL, Curran AP, Casey G, Witte JS. PMID: 14504207.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    55. High-resolution analysis of paraffin-embedded and formalin-fixed prostate tumors using comparative genomic hybridization to genomic microarrays. Am J Pathol. 2003 Mar; 162(3):763-70. Paris PL, Albertson DG, Alers JC, Andaya A, Carroll P, Fridlyand J, Jain AN, Kamkar S, Kowbel D, Krijtenburg PJ, Pinkel D, Schröder FH, Vissers KJ, Watson VJ, Wildhagen MF, Collins C, Van Dekken H. PMID: 12598311; PMCID: PMC1868117.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    56. Identification and fine mapping of a region showing a high frequency of allelic imbalance on chromosome 16q23.2 that corresponds to a prostate cancer susceptibility locus. Cancer Res. 2000 Jul 01; 60(13):3645-9. Paris PL, Witte JS, Kupelian PA, Levin H, Klein EA, Catalona WJ, Casey G. PMID: 10910080.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    57. Association between a CYP3A4 genetic variant and clinical presentation in African-American prostate cancer patients. Cancer Epidemiol Biomarkers Prev. 1999 Oct; 8(10):901-5. Paris PL, Kupelian PA, Hall JM, Williams TL, Levin H, Klein EA, Casey G, Witte JS. PMID: 10548319.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    58. Probing DNA sequences in solution with a monomer-excimer fluorescence color change. Nucleic Acids Res. 1998 Aug 15; 26(16):3789-93. Paris PL, Langenhan JM, Kool ET. PMID: 9685497; PMCID: PMC147755.
      View in: PubMed   Mentions: 27     Fields:    Translation:Cells
    59. Experimental Measurement of Aromatic Stacking Affinities in the Context of Duplex DNA. J Am Chem Soc. 1996 Aug 28; 118(34):8182-8183. Guckian KM, Schweitzer BA, Ren RX, Sheils CJ, Paris PL, Tahmassebi DC, Kool ET. PMID: 20882117; PMCID: PMC2946158.
      View in: PubMed   Mentions: 43     Fields:    
    60. Naphthalene, Phenanthrene, and Pyrene as DNA Base Analogues: Synthesis, Structure, and Fluorescence in DNA. J Am Chem Soc. 1996 Aug 21; 118(33):7671-7678. Ren RX, Chaudhuri NC, Paris PL, Rumney S, Kool ET. PMID: 20865136; PMCID: PMC2943137.
      View in: PubMed   Mentions: 41     Fields:    
    Pamela's Networks
    Concepts (296)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (55)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.